Wynzora (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Cream
- RxCUI
- 2471878
- RxNorm name
- Wynzora (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Cream
- Display name
- Wynzora (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Cream
- Full name
- Wynzora (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Cream
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Wynzora | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | MC2 Therapeutics Ltd | 36c5c818-0d40-445e-a3c0-0f46723a25e2 | 2023-11-29 | Warnings, Adverse reactions | 2471878 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 36c5c818-0d40-445e-a3c0-0f46723a25e2 | Wynzora 0.005 % / 0.064 % Topical Cream [PSN] · betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML Topical Cream [Wynzora] [SBD] · Wynzora (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Cream [SY] | 3 | 6 | These highlights do not include all the information needed to use WYNZORA Cream safely and effectively. See full prescribing information for WYNZORA Cream. WYNZORA ® (calcipotriene and betamethasone dipropionate) cream, for topical use Initial U.S. Approval: 2020 | 20231129 |